The Matrix HealthEvidence-based options, clinically reviewed.
Your The Matrix Health clinician will recommend the right therapy for your goals, medical history, and budget. Prices below are approximate and vary by pharmacy, dose, and supply.
Ozempic
Semaglutide · Weekly subcutaneous injection
Once-weekly semaglutide injection originally approved for type 2 diabetes, widely used off-label for weight management.
Generic Ozempic
Semaglutide (generic) · Weekly subcutaneous injection
A more affordable generic semaglutide option dispensed through our partner pharmacy, when available.
Wegovy
Semaglutide · Weekly subcutaneous injection
Higher-dose semaglutide formulation specifically approved by Health Canada for chronic weight management.
Mounjaro
Tirzepatide · Weekly subcutaneous injection
First dual GLP-1/GIP agonist, approved for type 2 diabetes and used off-label for significant weight loss.
Zepbound
Tirzepatide · Weekly subcutaneous injection
Tirzepatide branded specifically for chronic weight management. Availability in Canada may vary by pharmacy.
Rybelsus
Oral Semaglutide · Daily oral tablet
The first and only oral GLP-1 — a daily tablet for patients who prefer to avoid injections.
Contrave
Naltrexone / Bupropion · Daily oral tablet
An oral combination therapy that targets appetite and reward pathways in the brain — a non-injectable option.
Listed prices are approximate Canadian retail ranges and do not include your Matrix Health visit fee. Final medication cost is determined by our partner pharmacy at the time of dispensing and may vary based on dose and supply.